對(duì)照品 > 標(biāo)準(zhǔn)品 > 美國(guó)藥典 >
產(chǎn)品基本信息
產(chǎn)品編號(hào)：A637202
產(chǎn)品名稱：Anacetrapib-d3
產(chǎn)品CAS：1061715-90-9
規(guī)格含量：
產(chǎn)品價(jià)格：面議
聯(lián)系我們:
產(chǎn)品詳細(xì)介紹
標(biāo)準(zhǔn)品編號(hào):
A637202
名稱:
Anacetrapib-d3
別名:
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-2'-(methoxy-d3)-5'-(1-methylethyl)-4-(trifluoromethyl)[1,1'-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-(methoxy-d3)-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one; MK 0859-d3;
CAS號(hào):
1061715-90-9
備用CAS:
未標(biāo)記：875446-37-0
分子式:
C??H??D?F??NO?
分子量:
640.53
類別:
Standards; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
A labelled orally active and potent cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis, in particular dyslipidemia.
文獻(xiàn)
Krishna, R. et al.: Br. J. Clin. Pharmacol., 67, 520 (2009); Vergeer, M. et al.: Nat. Clin. Pract. Cardiovasc. Med., 5, 302 (2008); Masson, D.: Curr. Opin. Invest. Drugs, 10, 980 (2009);
?您的位置：
